Theravance Biopharma, Inc. (TBPH)
17.60
-0.20
(-1.15%)
USD |
NASDAQ |
Dec 10, 16:00
17.60
0.00 (0.00%)
After-Hours: 20:00
Theravance Biopharma Price: 17.60 for Dec. 10, 2025
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Perspective Therapeutics, Inc. | 2.555 |
| Skye Bioscience, Inc. | 1.16 |
| FibroGen, Inc. | 8.84 |
| Myomo, Inc. | 1.085 |
| VYNE Therapeutics, Inc. | 0.4039 |
Price Related Metrics
| PE Ratio | 31.30 |
| PS Ratio | 11.05 |
| Price to Book Value | 3.834 |
| Price to Free Cash Flow | 3.645 |
| Earnings Yield | 3.20% |
| Market Cap | 892.09M |
| Normalized PE Ratio | 31.30 |